|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
3 August 2015 |
|
Main ID: |
NCT02507882 |
|
Date of registration:
|
22/07/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma
|
|
Scientific title:
|
Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma |
|
Date of first enrolment:
|
January 2016 |
|
Target sample size:
|
405 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02507882 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Waleed Samir Abdelrazek, PhD |
|
Address:
|
|
|
Telephone:
|
+20507942901 |
|
Email:
|
waleed_samir1@yahoo.com |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- HCV-infected patients confirmed by RT-PCR with and without fibrosis, cirrhosis and
HCC
Exclusion Criteria:
- HCV/HIV co-infection
Age minimum:
10 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
HCV Infection ( Genotype 4)
|
|
Intervention(s)
|
|
Biological: miRNA quantification
|
|
Biological: IL28B Polymorphism
|
|
Primary Outcome(s)
|
|
IL-28B rs12979860 and rs4803217 Genotype evaluation
[Time Frame: 6 months to 1 year from the start of the study]
|
|
Specific miRNA levels and their association with degree of fibrosis, cirrhosis and HCC
[Time Frame: 1 to 2 years from the start of the study]
|
|
Secondary ID(s)
|
|
ELH - 2015 - IL28
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|